http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-094772-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c5e77c181522ee1fd44df1ae5ac2196 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20 |
| filingDate | 2014-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9325439b11c2eebfe9e59fd11dbc13ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04fffe1788edb1f78e48184a44b2d6e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c15f794195cfdab6f79c57c6863c122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db9483552fa38601d2dd66a89c0b775c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd1f418e057541453e75a236bd869471 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c0f81508bb009b848046100b031cc46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4aecd05fd457f1ef21a69ea64aa2996 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6abc40e4c4631a5972f2da145e3a98aa |
| publicationDate | 2015-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-094772-A1 |
| titleOfInvention | CYCLOPROPANOAMINE COMPOUND |
| abstract | The present provides a compound which has a specific lysine 1 demethylase inhibitory activity and is useful as a medicinal agent such as a prophylactic or therapeutic agent for cancer and diseases of the central nervous system. This refers to a compound represented by the formula (1). Claim 1: A compound represented by the formula (1) characterized in that A is a hydrocarbon group that optionally has a substituent (s), or a heterocyclic group that optionally has a substituent (s); R is a hydrogen atom, a hydrocarbon group that optionally has a substituent (s), or a heterocyclic group that optionally has a substituent (s); or A and R are optionally linked together to form a ring that optionally has a substituent (s); Q¹, Q², Q³ and Q⁴ each are independently a hydrogen atom or a substituent; Q¹ and Q², and Q³ and Q⁴, each are optionally linked together to form a ring that optionally has a substituent (s); X is a hydrogen atom, an acyclic hydrocarbon group that optionally has a substituent (s), or a saturated cyclic group that optionally has a substituent (s); Y¹, Y² and Y³ each are independently a hydrogen atom, a hydrocarbon group that optionally has a substituent (s), or a heterocyclic group that optionally has a substituent (s); X and Y¹, and Y¹ and Y², each are optionally joined together to form a ring that optionally has a substituent (s); and Z¹, Z² and Z³ each are independently a hydrogen atom or a substituent; or a salt thereof. |
| priorityDate | 2014-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.